| Dr William Lantz Effinger I, DO,MS | |
|
1891 Capital Cir Ne Ste 9, Tallahassee, FL 32308-4486 | |
| (888) 698-2714 | |
| (888) 698-2714 |
| Full Name | Dr William Lantz Effinger I |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1891 Capital Cir Ne Ste 9, Tallahassee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225327380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | OS11271 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Hospice Inc | Pensacola, FL | Hospice |
| Capital Regional Medical Center | Tallahassee, FL | Hospital |
| Tallahassee Memorial Healthcare | Tallahassee, FL | Hospital |
| Centre Pointe Health And Rehab Center | Tallahassee, FL | Nursing home |
| Heritage Healthcare Center At Tallahassee | Tallahassee, FL | Nursing home |
| Brynwood Health And Rehabilitation Center | Monticello, FL | Nursing home |
| Westminster Oaks | Tallahassee, FL | Nursing home |
| Pruitthealth - Southwood | Tallahassee, FL | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Effinger Health, Pa | 5799053476 | 3 |
News Archive
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels in the retina, leading to blindness.
Today, the Board of Directors for Legacy(SM) - a national public health foundation devoted to tobacco cessation and prevention - announced it will continue efforts to preserve tobacco funds in Ohio, by taking the battle to the Supreme Court of Ohio.
In this month's Physics World, Steve Haake, director of the Centre for Sports Engineering at Sheffield Hallam University in the UK, reveals that the men's 100 m sprint will be one event not to miss this summer.
Today it is not possible to predict spreading from malignant melanomas. Melanoma metastases are furthermore extremely difficult to eliminate as traditional treatment such as chemotherapy and radiotherapy is mostly ineffective. Only ten per cent of the patients survive once they reach an advanced stage with distant metastases.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
› Verified 7 days ago
| Entity Name | Effinger Health, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629515325 PECOS PAC ID: 5799053476 Enrollment ID: O20170621002500 |
News Archive
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels in the retina, leading to blindness.
Today, the Board of Directors for Legacy(SM) - a national public health foundation devoted to tobacco cessation and prevention - announced it will continue efforts to preserve tobacco funds in Ohio, by taking the battle to the Supreme Court of Ohio.
In this month's Physics World, Steve Haake, director of the Centre for Sports Engineering at Sheffield Hallam University in the UK, reveals that the men's 100 m sprint will be one event not to miss this summer.
Today it is not possible to predict spreading from malignant melanomas. Melanoma metastases are furthermore extremely difficult to eliminate as traditional treatment such as chemotherapy and radiotherapy is mostly ineffective. Only ten per cent of the patients survive once they reach an advanced stage with distant metastases.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Lantz Effinger I, DO,MS 1891 Capital Cir Ne Ste 9, Tallahassee, FL 32308-4486 Ph: (888) 698-2714 | Dr William Lantz Effinger I, DO,MS 1891 Capital Cir Ne Ste 9, Tallahassee, FL 32308-4486 Ph: (888) 698-2714 |
News Archive
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels in the retina, leading to blindness.
Today, the Board of Directors for Legacy(SM) - a national public health foundation devoted to tobacco cessation and prevention - announced it will continue efforts to preserve tobacco funds in Ohio, by taking the battle to the Supreme Court of Ohio.
In this month's Physics World, Steve Haake, director of the Centre for Sports Engineering at Sheffield Hallam University in the UK, reveals that the men's 100 m sprint will be one event not to miss this summer.
Today it is not possible to predict spreading from malignant melanomas. Melanoma metastases are furthermore extremely difficult to eliminate as traditional treatment such as chemotherapy and radiotherapy is mostly ineffective. Only ten per cent of the patients survive once they reach an advanced stage with distant metastases.
Biomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced it has retained Emerging Growth Research, LLP to manage its public relations and investor relations programs. Emerging Growth Research specializes in small market capitalization companies in the technology and biotechnology sectors.
› Verified 7 days ago
Dr. Danny Martinez, MD, MPH General Practice Medicare: Not Enrolled in Medicare Practice Location: 501 S Calhoun St, Tallahassee, FL 32399 Phone: 850-717-3269 | |
Dr. Joseph C Siano, D.O. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4283 Raleigh Way, Tallahassee, FL 32311 Phone: 850-243-3362 Fax: 850-765-0586 | |
Jimmy Pierre, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 2634 Capital Cir Ne, Tallahassee, FL 32308 Phone: 850-523-3261 Fax: 850-523-3411 | |
Dr. Kendis Archer, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4720 Silent Creek Ln, Tallahassee, FL 32303 Phone: 772-801-9885 | |
Dr. Allison M Akridge, DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 1264 Metropolitan Blvd, Tallahassee, FL 32312 Phone: 850-383-3382 | |
Marjorie Emery Kirsch, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2965 Municipal Way, Tallahassee, FL 32304 Phone: 850-606-8150 Fax: 850-487-7954 | |
Dr. Vicdia L Sostre Concepcion, MD General Practice Medicare: Medicare Enrolled Practice Location: 2181 Orange Ave E, Tallahassee, FL 32311 Phone: 352-548-6000 |